Specialization
Hospital Pharmacy
Focus of research
Pharmacology of CFTR modulators in Cystic Fibrosis
-
Real-world population pharmacokinetics of tezacaftor-ivacaftor in children with cystic fibrosis: The SYM-CF study
Vonk, S. E. M., Terheggen-Lagro, S. W. J., Haarman, E. G., Janssens, H. M., Maitland–van der Zee, A.-H. & Amsterdam Mucociliary Clearance Disease (AMCD) research group, Oct 2025, In: British Journal of Clinical Pharmacology. 91, 10, p. 2969-2978 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Real-world pharmacokinetics of elexacaftor-tezacaftor-ivacaftor in children with cystic fibrosis: a prospective observational study
Vonk, S. E. M., Terheggen-Lagro, S. W. J., Haarman, E. G., Hashimoto, S., Maitland-van der Zee, A. H., Mathôt, R. A. A. & Amsterdam Mucociliary Clearance Disease (AMCD) research group, May 2025, In: Journal of Cystic Fibrosis. 24, 3, p. 526-533 8 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Towards personalized medicine in cystic fibrosis: Focusing on clinical pharmacology of CFTR modulators
Vonk, S., 2025, 202 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
- All publications